Concussions have been brought to the forefront recently with a number of former Professional Athletes publicly addressing the Health issues they face as a result of repeated concussions throughout their careers, most notably Mohammed Ali. Lets not forget the blockbuster movie starring Will Smith aptly titled “Concussion”. As a nation we are also facing staggering numbers of Military personnel that have sustained Traumatic Brain Injuries defending our country.
Fearnot for there is hope on the horizon in the form of a research study being conducted with funding by Scythian BioSciences in the treatment of Concussion and Traumatic Brain Injury in partnership with the University of Miami Miller School of Medicine. Dr. Gillian Hotz is the Lead researcher, and she has been the Co-Director of the Miller school of Medicines Concussion program since 1995. Dr. Hotz is a nationally recognized expert in behavioral neuroscience as well as pediatric and adult neurotrauma, concussion management and Neuro rehabilitation.
Scythian Bioscience has invested $16 million into the 5 year grant with the process beginning in January of 2017. The research is being conducted in the hopes of developing a currently non-existent drug treatment plan utilizing cannabinoid-based medication. The first of its kind, that indicates a course of therapy to inhibit the immune response to concussions and also deter the accompanying inflammation which has shown itself to worsen brain injury by further pushing the brain against the bones of the skull.
Wouldn’t it be wonderful to be able to treat and hopefully improve the often catastrophic effects of head trauma with the wonderful minimal side effect component of Cannabis and Hemp?
I’ll continue to follow this study and update as possible.